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INTRODUCTION
The first human deaths due to air pollution were
recorded in the mid-20th century. There were 6,000 
cases of illness recorded in Donora, Pennsylvania, in
1948 and 20,000 in London in 1952; 15 and 4,000 cases
of death, respectively, were allegedly ascribed to air
pollution. Since then, many countries have adopted
standards of air quality in order to protect environmen-
tal and human health, although the quality of the air in
some industrialized countries remains worrying. Emerg-
ing countries in the Far East and South America are al-
so cause for concern because of the growth in the pop-
ulation, industrialization and transport (1).
The WHO World Health Report 2002 estimated that
air pollutants, particularly PM10, are associated with a
mortality rate of 5% for cancer of the respiratory sys-
tem, 2% for cardiovascular diseases and about 1% for
respiratory tract infections. These estimates consider
the mortality but not the morbidity rate, which would in-
crease proportionally the number of cases of these
pathologies, despite the difficulty in evaluation (2).
ENVIRONMENTAL POLLUTANTS
According to the Italian Presidential Decree no. 203
dated May 24th 1998, air pollution is defined as “any
modification to the normal composition or to the physi-
cal state of the air, due to the presence of one or more
substances in such quantities and characteristics as to
alter its healthiness and the normal environmental con-
ditions; this contamination can be directly or indirectly
dangerous for human health and could jeopardize
recreational and normal activities performed in the envi-
ronment. Moreover, this could seriously affect biological
resources, the ecosystem, and public and private tangi-
ble assets”.
The thus-defined pollutants, which can be in
gaseous, liquid or solid form, are commonly classified
as either primary or secondary. Primary pollutants are
released into the atmosphere directly by nature or as a
consequence of human activity. Many of these pollu-
tants, which have an elevated reactivity, either intrinsic
or sunlight-induced, can combine easily or react with
natural substances in the atmosphere, causing sec-
ondary pollutants.
The main pollutants derive from:
￿ the combustion process in car engines, domestic
heating and industrial equipment;
￿ wear and tear and the dispersion of materials, e.g. the
road surface and car tires;
￿ certain manufacturing processes.
Primary pollutants, which include nitrogen monoxide
(NO), carbon monoxide (CO), sulphur dioxide (SO2) and
volatile organic compounds, originate from the above
sources. 
Secondary pollutants include nitrogen dioxide (NO2),
ozone (O3), sulphuric acid (H2SO4), aldehydes, ketones,
peroxides and particulate matter (PM) (3).
Nitrogen oxides
Nitrogen oxides are highly reactive substances, and
most toxicological and epidemiological studies have fo-
cused on NO2. The main anthropogenic source of NO2 is
fossil combustion, especially in motor vehicles and in-
dustrial processes. NO2 concentrations have been seen
to peak in the morning and late afternoon, in conjunc-
tion with rush-hour traffic. Other natural sources of NO2
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and NO are bacterial metabolism, volcanic emissions
and photolytic reactions (4-6).
These pollutants have a toxic effect on the respirato-
ry, immune and hemocoagulative systems since they
are able to combine with haemoglobin, thereby reduc-
ing the activity of the immune system (7, 8).
Carbon monoxide (CO)
Carbon monoxide is a product of the incomplete
combustion of carbon-containing fuels and cigarette
smoking (9, 10).
CO is a ubiquitous, odourless and colourless gas,
which binds to hemoglobin with an affinity 250 times
that of oxygen. CO binding to hemoglobin, changing its
conformation, causes a reduced release of O2 at the tis-
sue level and cellular hypoxia. In addition, CO binds to
numerous other cellular (or extravascular) proteins, e.g.
cytochrome P450, catalase, peroxidases and myoglo-
bin, interfering with mitochondrial respiration.
At present, measuring CO concentration in the air
serves more as an indicator of combustion-derived pollu-
tion than one of toxicity. Only in a few specific cases, such
as in poorly ventilated areas, can CO reach a high enough
concentration to lead to intoxication (poisoning) (11).
Sulphurous anhydride/sulphur dioxide
SO2 is a soluble gas with a pungent smell and taste
that irritates the eyes and mucous membranes. Be-
cause of its strong affinity for water, most SO2 is re-
tained in the rhinopharynx, and only a small quantity
reaches the deepest areas. SO2 can cause bronchocon-
striction and phlogosis of the upper airway in subjects
occupationally exposed to high SO2 concentrations
(12). 
One of the main sources of SO2 is combustion, espe-
cially in diesel engines. High levels of SO2 have been as-
sociated with numerous air pollution catastrophes in the
20th century; morbidity and mortality in these episodes
are closely related to its role in the formation of particu-
late matter (sulphates).
Ozone
Ozone is a highly-reactive gas, and is naturally pre-
sent in the stratosphere, where it prevents high-energy
UV radiation from penetrating the atmosphere. Yet in
the troposphere, where ozone should not actually be
present, it is formed by the action of solar UV radiation
on nitrogen oxides and on hydrocarbons (photochemi-
cal smog), both of which are released by motor vehicles
and industrial processes. This is why the toxic effects of
ozone peak in the late-afternoon hours, especially on
sunny days. The toxicity of O3 derives from its tendency
to oxidize tissues. For instance, ozone can cause pre-
mature ageing of the parenchyma and the epithelial
structure, and hence reduced resistance to pathogenic
agents (13-15). 
Particulate matter
Airborne PM consists of a mixture of liquid and solid
air-suspended particles, which are released straight in-
to the atmosphere or after the transformation of gas in-
to particles from natural or human-induced processes
(16-19).
PM can be classified according to:
a) dimensions, into dust, smoke, smog or soot and fog;
b) origin, into primary PM (if emitted into the atmos-
phere) and secondary PM (if resulting from the phys-
iochemical transformation of gases);
c) source, into natural or anthropogenic (Tab. I)
The most important parameter for defining the toxic-
ity of PM is particle diameter. Ultrafine particles, the so-
called “Aitken nuclei”, 0.01 µm < UFPs > 0.1 µm in di-
ameter, usually result from the homogeneous nucleation
of oversaturated vapors, e.g. the combustion process,
forming SO2, NH3 and NOX.
The so-called “fine” particles, 0.1 µm < PM > 2.5 µm
in diameter, are the result of the coagulation of UF par-
ticles, the physiochemical transformation of gases into
particles (also known as heterogenic nucleation) or the
condensation of the gas on pre-existing particles in the
accumulation fraction rate. In industrialized countries,
the most common constituents include sulphates, ni-
trates, elemental and organic carbon, a variety of metals
deriving from combustion processes, and ammonium
ions. Sulphates, nitrates and ammonium are basically
the result of the transformation of SO2, NO2 and CO
from a gaseous to a particle state.
0.1 µm < PMs > 2.5 µm can also include particles of
biological origin, e.g. fungal spores, bacteria, pollen
grains and endotoxins. Fine particles are generally tooNodari et al
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small to deposit and too big to agglomerate and coales-
cence into larger particles, enabling them to remain in
the atmosphere for days and cover long distances.
2.5 µm < PMs > 10 µm, the so-called “coarse parti-
cles”, derive from grinding or erosion processes, and in-
clude windblown soil. They include elements that are
present in the soil or in sea salt, e.g. Si, Al, Ca, Fe, Mn,
Na, Sr and K.
Due to their fairly large size, these particles are usu-
ally released by the atmosphere and settle in a few
hours, and they are commonly found near the source of
emission, depending on its height (Fig.1).
EPIDEMIOLOGICAL STUDIES
Many published epidemiological studies link environ-
mental air pollution to the incidence of human illnesses.
TABLE I - SOURCES OF FINE PARTICULATE (Marconi A, Ann Ist Super Sanità 2003; 39 (3): 329-42, modified) 
Natural
Sea spray
Mineral dust carried by the wind
Volcanic emissions (directly emitted particles and those produced by the reaction of gaseous compounds)
Biogenic materials (directly emitted particles and secondary ones resulting from the condensation of organic substances emitted by
plants)
Smoke resulting from forest fires or burning vegetable matter
Products of natural gas particle conversion reactions (e.g. sulphates generated by reduced sulphur emitted by ocean surfaces and reac-
tions with marsh gases)
Anthropogenic
Particles emitted from industrial processes, combustion processes, means of transport, construction work (ash, smoke, road dust, etc.)
Products of the conversion of gases generated by the combustion of fossil materials
Fig. 1 - Classification of par-
ticulate matter according to its
dimensions (Brook RD, et al.
Circulation 2004; 109: 2655-
71, modified).Endothelial damage due to air pollution
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Even though many pollutants can cause diseases indi-
vidually or in combination (e.g. NO2, SO2 and O3), re-
search in the last few years has focused on PM (20-23).
The acute and chronic effects of PM10 on human health
have been described. There are many epidemiological
studies on short-term health effects and outcomes
(mortality, hospital admissions, symptoms); they are re-
lated to the modification of pollutant concentrations in
the short term. There are few studies on chronic effects,
and they are based on data (such as total mortality and
cardiovascular events) recorded in different geographic
areas with different concentrations of air pollutants.
Studies on the acute effects of air pollution
The global result of studies conducted in the U.S.A.
and Canada up until 1997 showed that each 10 µg/m3
increase in PM10 was associated with a 1% increase in
daily mortality and hospital admissions (24-26).
The European Approach Project (APHEA – 2) (27)
has observed 43 million people in 29 European cities
for 5 years: the estimated increase in daily all-cause
mortality was 0.6% for each 10 µg/m3 increase in
PM10. When also considering daily hospitalization for
BPCO and cardiovascular events in subjects aged
over 65, researchers observed an increased incidence
of 1% and 0.5%, respectively, for each 10 µg/m3 in-
crease in PM10. 
A similar North American study, the NMMAPS (Na-
tional Mortality, Morbidity and Air Pollution Studies)
(28), which involved 20 cities and more than 50 million
people, reported a 0.5% increase in daily all-cause mor-
tality for each 10 µg/m3 increase in PM10.
Two MISA studies have been conducted in Italy:
MISA 1 (Meta Analysis of the Italian Studies on the
short-term effects of air pollution) produced - for the
first time in Italy - a complete estimate of the short-term
effects of air pollutants on human health; the MISA 2
study, conducted between 1996 and 2002, considered
a larger population (9 million people), and included
Southern Italy (29). In conjunction with the increased
concentration of air pollutants studied (PM10, CO, NO2),
researchers observed an increase in daily all-cause and
cardio-respiratory mortality, as well as an increase in
hospital admissions due to cardiac and respiratory dis-
eases. The association between the concentration of
pollutants and the incidence of illness depends on the
type of pollutant and the considered outcome. For daily
all-cause mortality, for instance, the increased risk is
evident within a few days of the peak in pollution (2 days
for PM10, up to 4 days for CO and NO2). The total daily all-
cause impact on mortality for gaseous pollutants such as
CO and NO2 is between 1.4% and 4.1%; PM10 evaluation
is more difficult because of the differences in the esti-
mates of the cities considered (0.1% - 3.3%). It is agreed,
however, that restrictive measures for controlling PM10, if
applied until 2010, could save 900 lives (1.4%). Some re-
cent studies conducted in Austria, France and Switzer-
land have indicated PM10 as being responsible for 6% of
total deaths, i.e. 40,000 deaths each year, half of which
are attributed to urban traffic (30).
Finally, some recent studies conducted in the United
States and Europe have shown a high number of hospi-
tal admissions due to cardiovascular problems - 0.8%
heart failure and 0.7% ischemic heart disease - as a
consequence of each 10 µg/m3 increase in PM10. Other
studies have reported a higher incidence of hyperten-
sion, myocardial ischemia during stress-testing, ar-
rhythmias and stroke in the presence of elevated PM10
levels (31-34).
Chronic effects of pollutants
The Six Cities Study (35) was the first prospective
study to demonstrate the long-term negative effects of
pollutants on health. Cardiovascular mortality is directly
related to pollution, with a RR of mortality of 1.26%
among 8,111 patients with 14-16 years of follow-up.
The data were confirmed, even after adjustment for age,
gender, smoking, body mass index, occupational expo-
sure and diabetes. Of the 1,401 deaths, 646 were due to
cardiovascular causes.
The ACS Cancer Prevention II Study (28), involving
500,000 patients living in 50 different countries with a
16-year follow-up, confirmed these data. Each 10
µg/m3 increase in PM2.5 resulted in an increase in dai-
ly all-cause, cardiopulmonary and lung cancer mortal-
ity of 4%, 6%, and 8%, respectively. PM2.5, sulphuric
dioxide, sulphate particles and O3 were the most dan-
gerous pollutants. Lastly, Hoek et al (36) pointed out
that exposure to toxic substances may vary from
place to place within the same town. Living near a ma-
jor road was associated with increased cardiopul-
monary mortality (RR 1.95).Nodari et al
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BIOLOGICAL EFFECTS
The biological mechanism correlating air pollutants
with cardiac diseases are only partially understood. Air
pollutants can affect the cardiovascular system directly
(within a few hours). Some gaseous pollutants and ul-
trafine particles go straight into the circulatory system,
penetrating the pulmonary epithelium. Other pollutants
act indirectly (within several hours or days) via pul-
monary oxidative stress, leading to a systemic inflam-
matory state (17-19).
The potential mechanism of the effects of PM10 on the
cardiovascular system is shown in Figure 2.
Oxidative stress and systemic or pulmonary
inflammatory state
Several studies conducted in in vitro animal and cel-
lular models have shown that exposure of lung tissue to
PM10 and O3 produces an inflammatory response and
that the presence of metal elements enhances the toxic
effects by increasing oxidative stress (37-44).
A recent study conducted on rats showed a doubling
in reactive oxygen species in hearts and lungs after 2
hours’ exposure to PM2.5 (45).
In addition, exposure to high concentrations of PM2.5
caused an increase in levels of markers of lipid and pro-
tein oxidation in human beings (46). Oxidative stress
causes the activation of transcription factors, e.g. NFKB
and protein-1 activator, which are linked to the produc-
tion of cytokines, chemokines and other proinflammato-
ry mediators (47).
PM2.5 induces apoptosis and necrosis of macro-
phages and respiratory epithelial cells; it possibly de-
creases immunitary defenses and increases airway re-
activity (48).
Finally, the inflammatory intrapulmonary response is
due in part to stimulation by the irritant particles of sen-
sory neurons. They stimulate the release of neuropep-
tides (e.g. substance P and neurokinin A), which in turn
stimulate the production of cytokines, vasodilatation
and mucus secretion. Moreover, neuropeptides in-
crease the inflammatory response by acting on epithe-
lial and smooth muscle cells as well as on polymor-
phonuclear leukocytes, lymphocytes, eosinophils and
so on (49-51).
During some recent studies, rats were given 5 mg
PM10 intrapharyngeally twice a week; an increase in the
production and release of polymorphonuclear leuko-
cytes into the bone marrow was observed three weeks
latee (52). In addition, more extensive inflammation was
seen in the alveolar macrophages, epithelial cells and
Fig. 2 - Possible biological mechanisms
linking PM to cardiovascular disease.
(Brook, RD et al, Circulation 2004; 109:
2655-71, modified).Endothelial damage due to air pollution
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airway walls (53). Additional observational studies have
confirmed that healthy patients exposed to high PM10
and O3 concentrations produce an inflammatory re-
sponse. This is confirmed by an increase in B and T
cells, polymorphonuclear leukocytes, mast cells, and
inflammatory and fibrinogenous mediators (54, 55).
Other studies have shown that air pollution can induce
a systemic inflammatory response, regardless of the ef-
fects on the lungs: exposure to forest fire smoke (mea-
sured as PM10 and SO2) causes the bone marrow to re-
lease immature polymorphonucleates cells even if lung
function has not been manifestly affected (56) (Fig. 3).
Systemic inflammation and oxidative stress
effects on the cardiovascular system
Nearly 10 years ago, Seaton et al (57) put forward the
hypothesis that exposure to PM10 could provoke alveo-
lar inflammation, which in turn could lead to the wors-
ening of pre-existing diseases, increased blood coagu-
lability and a high risk of cardiovascular events. Addi-
tional studies indicated that exposure to PM10 increases
fibrinogen, which is a well-known independent risk fac-
tor for myocardial infarction and stroke (58-61). 
An increased concentration of granulocyte macro-
phage colony stimulating factor (GM-CSF), IL-6 and IL-
1 was observed in healthy males exposed regularly to
air pollutants, giving a high risk for cardiovascular
events and mortality (62-65). In the bone marrow, GM-
CSF stimulates the differentiation and the release of
granulocytes and monocytes as well as their degranula-
tion at a peripheral state. IL-1 stimulates the inflamma-
tory stage through the production of further cytokines
and the activation of endothelial cells. IL-6 stimulates
the synthesis of C-reactive protein in the liver, i.e. CPR,
fibrinogen and thrombopoiesis in the bone marrow (66-
68). These three cytokines, especially when combined,
are able to promote a systemic inflammatory response
with an increase in leukocytes, platelets, and proinflam-
matory and prothrombotic proteins. They also activate
leukocyte and endothelium response, promoting the re-
cruitment and migration of the inflammatory cells into
the arterial wall.
High CPR levels have been associated with increased
cardiovascular risk. In patients with coronary artery dis-
ease, CPR enhances endothelial dysfunction, directly
stimulating the production of “foam cells”, the migration
of monocytes into the arterial wall, the inhibition of NO-
synthase activity, and the expression of adhesion mole-
cules along with prothrombotic factors (69-71).
As a result, air pollution, and the systemic inflamma-
tion associated with it, plays an important role in pro-
moting atherosclerosis formation in the long term and
acute plaque instability in the short term. A study of hy-
Fig. 3 - Increase in white blood cells count in relation to PM10 lev-
els (Tan WC et al, Am J Respir Crit Care Med 2000; 161: 1213-7) 
(modified).
Fig. 4 - In dogs, the inhalation of concentrated ambient particles
(CAPs) increases susceptibility to myocardial ischemia (Wellenius
et al, Environ Health Perspect 2003; 111: 402-8) (modified).
402-8Nodari et al
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perlipidemic rabbits exposed to PM revealed a progres-
sion of coronary artery disease and high lipid levels af-
ter 4 weeks. The degree of plaque formation is linked to
the number of alveolar macrophages that phagocy-
tosed PM10 (72). 
Many studies correlate atmospheric pollution with
vascular tone alterations. One on healthy patients ex-
posed to PM and O3 for two hours showed elevated ar-
terial vasoconstriction. Reduced NO-production and a
higher concentration of endothelins have also been ob-
served (73-76).
The ULTRA study (Exposure and Risk Assessment
of Fine and Ultrafine Particles in Ambient Air) showed
that ischemic patients, exposed to PM two days be-
fore submaximal exercise, had an increased ST-seg-
ment depression during the test. This suggests that
air pollution increases susceptibility to myocardial is-
chemia and infarction (77). The same findings of high-
er susceptibility to myocardial ischemia were ob-
tained in an experimental study (78) of dogs exposed
to concentrated ambient particles (CAP) three or four
consecutive times a week for 6 months. They suffered
occlusion of the left anterior descending coronary
(Fig. 4).
Alterations in sympatho-vagal tone
The increased cardiovascular mortality following expo-
sure to atmospheric pollutants can be explained by alter-
ations in the autonomic nervous system, as shown by heart
rate variability (HRV), resting heart rate and blood pressure.
Reduced HRV detected by analysis of time domain (RR
intervals) and frequency domain (LF/HF rate) is a predictive
factor for increased cardiovascular morbidity and mortality,
especially in patients with severe heart disease (79). 
The reduction in HRV linked to exposure to PM10 is an
expression of the imbalance between the sympathetic and
parasympathetic nervous systems. Patients with a car-
dioverter defibrillator maintained for three years showed a
correlation between the number of discharges and NO2 and
CO concentration (80). Increased mortality for threatening
arrhythmias is related to PM10 exposure in the week before
the event.
This clinical evidence is supported by experiments con-
ducted on animals, for instance increased LF/HF rate in
dogs exposed to PM for 6 hours on three consecutive days.
Another study reported decreased HRV and increased ar-
rhythmia frequency in a myocardial infarction model (81).
The pathogenetic mechanisms causing the alterations in
sympatho-vagal tone remain unclear, however,  they could
involve activation of pulmonary neural reflex, direct effects
on cardiac ion channels and the systemic inflammatory
state (82-84). In response to the inflammation caused by
atmospheric pollutants, the autonomic nervous system
produces neuropeptides and catecholamines, which can
alter the regulation of the cardiac autonomic nervous sys-
tem.
Exposure to PM10 can, in fact, induce a systemic re-
sponse with an elevated sympathetic systemic tone and
higher resting heart rate (0.8 beats/min each 100 µg/m3 in-
crease), leading to HRV reduction and major susceptibility
to life-threatening ventricular tachyarrhythmias. Finally,
PM10 influence on pulmonary receptors could stimulate the
growth of parasympathetic tone and be a predisposing fac-
tor for bradyarrhythmias.
CONCLUSIONS
Although the results of observational studies may be
influenced by numerous factors, such as the character-
istics of the pollutant, the population studied, the meth-
ods and some confounding factors, certain conclusions
can be drawn.
Exposure to high PM concentrations significantly in-
creases cardiovascular mortality rate and hospital ad-
missions due to pulmonary CV diseases, especially in
high-risk patients.
Evidence of such effects on public health has spurred
international organizations to review the regulations for
PM10 and PM2.5 concentrations, taking place in the Unit-
ed States in 1987 and 1997. The E.U. has established
the maximum concentration for PM10, but not for PM2.5,
TABLE II - LIMIT VALUE OF PM10 PROVIDED BY UE
Annual Limit  Date of current  Limit Value/24 h
Value (µg/m3) entry (µg/m3)
48.0 2000 75
46.4 2001 70
44.8 2002 65
43.2 2003 60
41.6 2004 55
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